Pressemitteilung -
Certmedica supports digital weight loss with My-formoline app
Lose weight sustainably for your health now:
formoline L112 and extra motivation with the My-formoline companion app
With the My-formoline app, overweight patients now have an innovative digital solution that supports the intake of formoline L112 and paves the way to a sustainably healthy lifestyle.
Behavior management plays a decisive role in the treatment of overweight and obesity and its accompanying diseases and sequelea. formoline L112 and the new My-formoline app offer scientifically based and structured support that can positively influence the achievement of sustainable weight reduction and weight maintenance in everyday life.
Scientifically proven weight loss performance
formoline L112 is a medical product that contains the active ingredient polyglucosamine L112. Several clinical studies1-3confirm the excellent weight reduction capacity and tolerability of formoline L112. Using formoline L112, body weight was significantly reduced1-3 and in a three-month study, weight loss was tripled compared to placebo1. Key health parameters such as insulin sensitivity1, blood lipid levels1,2, hypertension2 and abdominal obesity2 also improved. Practical data over 10 years also confirm the long-term use of formoline L112 for weight maintenance4.
Why a companion app?
The efficacy of highly effective pharmaceuticals or medical devices can be impaired by inadequate dosing, a suboptimal timing strategy or individualized, non-evidence-based intake. A similar phenomenon can be seen in the inadequate consideration of therapy recommendations, for example with regard to changes in diet and exercise behavior. This is where the My-formoline app offers digital support.
formoline L112 and the My-formoline app - a strong team for losing weight
The My-formoline app accompanies users and supports doctors and pharmacists in promoting their patients' adherence to therapy. This is because the effectiveness of the preparation is optimized by taking it correctly and integrating it into a healthy lifestyle. The application has a wide range of functions aimed at motivating users to lose weight, optimize their diet and stay active in the long term. The My-formoline app is now available in the popular app stores.
These main functions of the My-formoline app support weight loss
The app offers a variety of customizable functions:
1. weight tracking and success monitoring: The My-formoline app offers clear weight tracking that allows users to clearly track their progress. Users can enter both their current weight and their desired weight to keep track of their progress. In addition, the app creates weekly reviews that visualize progress and enable transparent monitoring of success. These reports motivate users, provide feedback on the progress they have made and help them to pursue their goals in the long run.
2. intake reminders: Regular intake of formoline L112 is crucial to achieve the full effect of the product. The app ensures that users take the tablets at the right time by triggering discreet reminders before meals. This integrates the intake seamlessly into everyday life and ensures the optimal effect of the medical product.
3. promoting exercise and activity: Exercise is an important part of a healthy lifestyle. Sports videos specially developed with a personal trainer motivate people to join in. These videos offer suitable exercises for every fitness level and make it easier to integrate exercise into everyday life. The app also includes an integrated pedometer that helps users to monitor their daily activity and set their own exercise goals. Whether it's walking, climbing stairs or sporting activities - the app regularly reminds users to stay active.
4. drink reminder: Adequate fluid intake is crucial for well-being and weight regulation. The My-formoline app regularly reminds users to drink enough water. This function not only helps to optimize hydration, but also helps to stimulate the metabolism and detoxify the body.
5. practical nutrition tips and recipe ideas: To make it easier for users to switch to a healthy diet, the app offers a wide selection of recipes with nutritional information. These cover different needs - whether vegetarian, lactose-free or recipes with just five ingredients. The tips and ideas are practical, easy to implement and provide variety in everyday nutrition.
6. knowledge articles for lasting success: The app has an extensive library of science-based articles on the topics of weight loss, nutrition and a healthy lifestyle. These articles not only provide valuable tips and insights, but also promote a better understanding of the psychology of weight loss, the right motivation and the importance of healthy habits. They help users to stick to their goals in the long term and develop a conscious approach to their lifestyle.
With these versatile functions, the My-formoline app is a very helpful tool that accompanies users every step of the way on their journey to a healthier life.
The future of the My-formoline app - further development in planning
Certmedica already has concrete plans for the further development of the My-formoline app. In the future, even more functions are to be integrated and offer users even more support on their path to a healthy life:
- Integration of health parameters recorded via wearables, bioimpedance scales and other measuring devices
- Integration of fitness trackers for more precise recording of other activities such as running, cycling or swimming as well as rest and sleep phases
- Relaxation and stress management exercises to help users improve their mental health - an important aspect that is often overlooked when losing weight.
- Integration of nutrition trackers for more precise recording of calorie intake and nutrients.
The app is initially available in German-speaking countries, with the exception of Switzerland. The app is currently being prepared for launch in other countries.
About formoline L112
formoline L112 is a non-prescription medical device in tablet form whose efficacy and safety have been clinically tested. It is also the first of its kind to be approved under the new European legislation (EU) 2017/745 (MDR). It contains the active ingredient polyglucosamine L112, a dietary fiber that binds significant amounts of dietary fat and thus reduces its absorption from the intestine. It can also bind oxidized fats and cholesterol. In this way, formoline L112 supports weight reduction and control and has a side effect of lowering LDL cholesterol. In a one-year study, the addition of formoline L112 to two daily meals led to a more significant weight reduction than a change in lifestyle alone. On average, participants taking formoline L112 lost 12 kilograms over the course of the year. The clinical studies also show positive effects and improvements in systemic inflammation (hsCRP), insulin levels, insulin resistance and blood pressure. Certmedica is continuously investing in clinical studies to expand the medical application of the formoline product range and to address new patient groups.
Clinical studies: 1) Rondanelli, M. et al. (2023). A randomized, double-blind, placebo-controlled clinical trial to evaluate the effect of a medical device containing polyglucosamine L112 on weight in a group of overweight and obese subjects. Nutrients. 2023; 15(16):3516. DOI: 10.3390/nu15163516 - 2) Cornelli, U. et al (2017). “Long-term treatment of overweight and obesity with polyglucosamine (PG L112): Randomized trial versus placebo in subjects after caloric restriction” Curr Dev Nutr 2017;1:e000919. DOI: 10.3945/cdn.117.000919. - 3) Stoll M. et al. (2017): Randomized, double-blind, clinical trial comparing orlistat 60 mg and a tailored polyglucosamine, two treatments for the management of overweight and obesity. BMC Obesity 4(4): 1 - 9. DOI 10.1186/s40608-016-0130-4. - 4) Grebe, W. et al. (2024): 'Sustained weight control over ten years: healthier diet, more exercise and fat reduction with polyglucosamine L112', literature review; Medizin Report aktuell No. 534104 in: CME 3/2024
Links
Themen
Kategorien
About Certmedica International
Die Certmedica International GmbH ist ein privates Gesundheitsunternehmen, das seit 2005 in Aschaffenburg im Großraum Frankfurt am Main, Deutschland, ansässig ist. Es strebt danach, ein weltweit führendes Unternehmen in den medizinischen Bereichen Übergewicht und Adipositas sowie den damit verbundenen Krankheiten und dem metabolischen Syndrom zu werden. Als solches entwickelt, produziert und vertreibt das Unternehmen Medizinprodukte, Nahrungsergänzungsmittel und Kosmetika, die u.a. den Standards der ISO 13485 und der Verordnung (EU) 2017/745 (MDR) entsprechen. Darüber hinaus handelt Certmedica als pharmazeutischer Großhändler nach §52a AMG mit Arzneimitteln. Heute ist Certmedica über den eigenen Apothekenvertrieb in Deutschland und Österreich sowie über das internationale Vertriebsnetz in über 40 Ländern weltweit erfolgreich tätig. Mit den starken Eigenmarken formoline® und aldiamed® hat Certmedica die Nummer 1 der OTC-Produkte gegen Fettleibigkeit im Heimatmarkt und weitere hochwertige Produkte im Portfolio, deren Wirksamkeit und Nutzen durch klinische Studien belegt sind.
Kontakt:
Certmedica International GmbH
Magnolienweg 17
63741 Aschaffenburg
+49 6021 15093 0
PR@certmedica.de
www.certmedica.de // www.L112.com